Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) Trend Analysis released that it has received a $1.1M refund of the before paid PDUFA filing fee related to the granting of orphan drug status of Lymphoseek (technetium Tc 99m tilmanocept) injection in head and neck cancers. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) stock price closed at $1.02 with the total traded volume of 1.95 Million shares. Its price to sales ratio ended at 54.88. Its market capitalization is 153.2 Million. The stock owned by the Financial Institutions was 37.00% while by insiders was 0.30%.Hercules Offshore, Inc. (NASDAQ:HERO) Trend Analysis released that it has promoted Troy Carson to SVP as well as CFO, effective November 21, 2014; Stephen Butz, resigned as the co's EVP and CFO effective November 21, 2014. The firm has promoted Troy Carson to Senior Vice President and CFO, effective November 21, 2014. Hercules Offshore, Inc. (NASDAQ:HERO) has the market capitalization of 258.9 Million. Shares of firm moved up 2.55% to close at $1.61 with the total traded volume of 1.6 Million. The firm has current ratio of 2.30 for the most recent quarter.JinkoSolar Holding Co., Ltd. (NYSE:JKS) Trend Analysis released that its wholly owned subsidiary, JinkoSolar U.S. INC., has reached a $20M two-year credit contract with Wells Fargo Bank. Borrowings under the new credit contract will be used to support JinkoSolar US's working capital and business operations. JinkoSolar Holding Co., Ltd. (NYSE:JKS) begun last trade with a price of $23.71 and throughout the trading session climbed at a high of $23.88. The day-trade ended with -1.39% to $23.41. The stock is going forward to its 52 week low with 20.55% and lagging behind from its 52 week high price with -38.36%. JKS last month stock price volatility remained 6.23%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
